217 related articles for article (PubMed ID: 8941916)
1. Homocysteinemia and vascular disease in end-stage renal disease.
Dennis VW; Robinson K
Kidney Int Suppl; 1996 Dec; 57():S11-7. PubMed ID: 8941916
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinaemia and end stage renal disease.
Gupta A; Robinson K
J Nephrol; 1997; 10(2):77-84. PubMed ID: 9238614
[TBL] [Abstract][Full Text] [Related]
4. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.
Verhoef P; Meleady R; Daly LE; Graham IM; Robinson K; Boers GH
Eur Heart J; 1999 Sep; 20(17):1234-44. PubMed ID: 10454975
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.
Robinson K; Gupta A; Dennis V; Arheart K; Chaudhary D; Green R; Vigo P; Mayer EL; Selhub J; Kutner M; Jacobsen DW
Circulation; 1996 Dec; 94(11):2743-8. PubMed ID: 8941098
[TBL] [Abstract][Full Text] [Related]
8. Association between serum homocysteine, vitamin B12, folate and Thai coronary artery disease patients.
Leowattana W; Mahanonda N; Bhuripunyo K; Pokum S
J Med Assoc Thai; 2000 May; 83(5):536-42. PubMed ID: 10863900
[TBL] [Abstract][Full Text] [Related]
9. Relationships between homocysteine and related amino acids in chronic hemodialysis patients.
McDonald SP; Whiting MJ; Tallis GA; Barbara JA
Clin Nephrol; 2001 Jun; 55(6):465-70. PubMed ID: 11434358
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
12. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
[TBL] [Abstract][Full Text] [Related]
13. The C677T thermolabile variant of methylene tetrahydrofolate reductase on homocysteine, folate and vitamin B12 in a hemodialysis center.
Trimarchi H; Genoud V; Schiel A; Castañon M; Freixas E; Diaz ML; Schropp J; Martino D; Pereyra H; Kordich L
Medicina (B Aires); 2002; 62(2):149-53. PubMed ID: 12038037
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis.
Moustapha A; Gupta A; Robinson K; Arheart K; Jacobsen DW; Schreiber MJ; Dennis VW
Kidney Int; 1999 Apr; 55(4):1470-5. PubMed ID: 10201012
[TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine concentration changes after renal transplantation in children.
Merouani A; Delvin EE; Genest J; Rozen R; Lambert M
Pediatr Nephrol; 2002 Jul; 17(7):520-3. PubMed ID: 12172766
[TBL] [Abstract][Full Text] [Related]
16. Elevated homocysteine levels in patients with end-stage renal disease.
Nair AP; Nemirovsky D; Kim M; Geer EB; Farkouh ME; Winston J; Halperin JL; Robbins MJ
Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
[TBL] [Abstract][Full Text] [Related]
17. [Plasma homocysteine levels in patients with ischemic cerebral infarction].
Vila N; Deulofeu R; Chamorro A; Piera C
Med Clin (Barc); 1998 May; 110(16):605-8. PubMed ID: 9656197
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
[TBL] [Abstract][Full Text] [Related]
19. The methionine-homocysteine cycle and its effects on cognitive diseases.
Miller AL
Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
[TBL] [Abstract][Full Text] [Related]
20. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
